This article first appeared on GuruFocus. Dr. Lal PathLabs Ltd (NSE:LALPATHLAB) is set to release its Q2 2026 earnings on Oct 31, 2025. The consensus estimate for Q2 2026 revenue is $7.38 billion, and ...

Diagnostics services company Dr Lal Path Labs on Friday announced an interim dividend of Rs 7 per equity share for the financial year 2025-26. The company also declared a 1:1 bonus issue where it will ...